期刊文献+

不同免疫抑制剂对肝移植术后CD4^+CD25^+FoxP3^+调节性T细胞的影响 被引量:9

Effects of different immunosuppressants on peripheral CD4^+ CD25^+ FoxP3^+ regulatory T cells in post liver transplant patients
原文传递
导出
摘要 目的 评价免疫抑制剂对肝移植术后患者外周血CD4^+ CD25^+ FoxP3^+调节性T细胞(regulatory T cell,Treg)的影响.方法 收集肝移植术后6个月以上状态稳定的肝移植患者91例.将患者按使用免疫抑制剂的种类及谷值浓度分为2组,Rapa组8例,FK506组83例,另设正常对照组20例,比较各组患者Treg比例情况.结果 Rapa组患者Treg比例为10.36%±2.52%,FK506组患者Treg比例为6.97%±3.28%,而正常对照组为6.66%±2.41%,Rapa组分别高于FK506组和正常对照组(P=0.004、P=0.005),但FK506组与正常对照组比较差异无统计学意义(P =0.684).FK506<7 ng/ml的低浓度FK506患者65例,Treg比例为7.56%±3.31%,FK506 ≥7 ng/ml高浓度组患者18例,Treg比例为4.84%±2.11%,差异有统计学意义(P=0.001).直线相关分析显示,FK506谷值浓度与Treg比例间并无直线相关关系(r=-0.119,P=0.284),但与Treg绝对数量具有直线相关(r =0.307,P=0.005).结论 肝移植术后长期免疫抑制治疗中,免疫抑制剂对CD4^+ CD25^+FoxP3^+ Treg比例有显著影响.选择合适的免疫抑制剂种类及剂量,有助于提高移植受者体内Treg比例. Objective To evaluate the effect of immunosuppressants on CD4^+ CD25^+ FoxP3^+ regulatory T cells (Treg) in the peripheral blood of patients post liver transplantation (LT).Methods A total 91 patients who received LT with steady clinic state for more than 6 months were included.Patients were divided into tacrolimus (FK506) group and rapamycin (Rapa) group according to the type of immunosuppressant.FK506 therapy patients were subdivided into low concentration group (〈 7.0 ng/ml) and high concentration group (≥7.0 ng/ml).Proportions of CD4^+ CD25^ + FoxP3^ + Treg in the peripheral blood of recipients were studied among the groups.Results The Treg proportion was 10.36% ± 2.52% in Rapa group (8 cases).In FK506 group (83 cases),the Treg proportion was 6.97% ±3.28%.Compared to the proportion of 6.66% ±2.41% in the healthy group,it was higher in Rapa group than that in FK506 group and in healthy group (P =0.004,P =0.005),respectively.In FK506 group,there were 65 cases on low FK506 concentration group with Treg proportion of 7.56% ± 3.31%.In high concentration group (18 cases),the proportion of Treg was 4.84% ± 2.11% (P =0.001).There was no linear correlation between FK506 trough concentration and proportion of Treg (r =-0.119,P =0.284).However,there was significant correlation between FK506 concentration and the number of Treg (r =0.307,P =0.005).Conclusions Long-term immuno-suppressive therapy significantly affects the proportion of CD4^ + CD25 ^+ FoxP3 ^+ Treg.
出处 《中华普通外科杂志》 CSCD 北大核心 2015年第2期126-129,共4页 Chinese Journal of General Surgery
基金 天津市卫生局科技基金资助项目(2013KZ035)
关键词 肝移植 免疫抑制剂 T淋巴细胞 调节性 Liver transplantation Immunosuppressive agents T-lymphocytes,regulatory
  • 相关文献

参考文献13

  • 1Pilat N, Baranyi U, Klaus C, et al. Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning [J]. Am J Transplant, 2010, 10(4) : 751-762.
  • 2Fujiki M, Esquivel CO, Martinez OM, et al. Induced tolerance to rat liver allografts involves the apoptosis of intragraft T cells and the generation of CIM + CD25 + FoxP3 + T regulatory ceils [ J ]. Liver Transpl, 2010, 16(2) : 147-154.
  • 3郭勇,陶崇林,章圣辉,廖毅,张启瑜.门静脉高压症脾功能亢进患者CD4+CD25+CD127low/-调节性T细胞和Foxp3的表达及其意义[J].中华普通外科杂志,2010,25(4):337-338. 被引量:2
  • 4Haxhinasto S, Mathis D, Benoist C. The AKT-mTOR axis regulates de novo differentiation of CD4 + FoxP3 + cells [ J ]. J Exp Med, 2008, 205(3) : 565-574.
  • 5Delgoffe GM, Kole TP, Zheng Y, et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment [J]. Immunity, 2009, 30(6): 832-844.
  • 6Demirkiran A, Hendrikx TK, Baan CC, et al. Impact of immunosuppressive drugs on CIM + CD25 +FoxP3 + regulatory T cells: does in vitro evidence translate to the clinical setting? [ J]. Transplantation, 2008, 85 (6) : 783-789.
  • 7Lu L, Qian XF, Rao JH, et al. Rapamycin promotes the expansion of CIM+ FoxP3+ regulatory T cells after liver transplantation [ J ]. Transplant Proc, 2010, 42 ( 5 ) : 1755-1757.
  • 8Xu G, Wang L, Chen W, et al. Rapamycin and tacrolimus differentially modulate acute graft-versus-host disease in rats after liver transplantation [ J]. Liver Transpl, 2010, 16 (3) : 357- 363.
  • 9Chu Z, Zhang J, Zhao Y, et al. Influence of immunosuppressive drugs on the development of CIM + CD25hlsh FoxP3 + T cells in liver transplant recipients [ J ]. Transplant Proc, 2010,42 ( 7 ) : 2599-2601.
  • 10Kim SH, Oh EJ, Ghee JY, et al. Clinical significance of monitoring circulating CIM + CD25 + regulatory T cells in kidney transplantation during the early posttransplant period [ J ]. J Korean Med Sci, 2009,24( Suppl 1 ) : S135-142.

二级参考文献5

  • 1Hartigan-O'Connor DJ,Poon C,Sinclair E,et al.Human CD4^+ regulatory T cells express lower levels of the IL-7 receptor alpha chain(CD127),allowing consistent identification and sorting of live cells.J Immunol Meth,2007,319:41-52.
  • 2Liu WH,Putnam AL,Zhou XY,et al.CD127 expression inveresely conelates with FoxP3 and suppressive funotion of human CD4^+ T reg cells.J Exp Med,2006,203:1701-1711.
  • 3Shevach EM.CD4^+CD25^+ suppressor T cells:more questions than answers.Nat Rev Immunol,2002,2:389-400.
  • 4Sakaguchi S.The origin of FOXP3-expressing CD4^+ regulatory T cells:thymus or periphery.J Clin Invest,2003,112:1310-1312.
  • 5姜洪池,乔海泉,代文杰.脾脏外科:近20年的进展与展望[J].中华肝胆外科杂志,2002,8(1):3-6. 被引量:71

共引文献1

同被引文献64

引证文献9

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部